Trial intelligence / Profile preview

Nadolol in Mild Asthma

NCT01804218Phase 2Unknown

Sponsor
Invion Limited
Start
Mar 2013
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nadolol in asthma, sponsored by Invion Limited. Status: unknown.

02

Drugs

nadolol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01804218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01804218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call